Navigation Links
Clinical Data Reported on Vidaza in Hematologic Malignancies and,Advanced Solid Tumors

sed on current expectations and involve a number of known and unknown risks and uncertainties that could cause the final results to differ significantly from the results summarized by such statements. Some of the clinical trials described in this release are being conducted by independent investigators and Pharmion does not control and cannot predict the final results of those trials. Top line or preliminary results may not be confirmed upon full analysis of the detailed results of a trial and additional information relating to the safety, efficacy or tolerability of Vidaza may be discovered upon further analysis of clinical trial data and upon review and analysis of data from other clinical trials. Additional risks and uncertainties relating to Pharmion and its business can be found in the "Risk Factors" section of Pharmion's Quarterly Report on Form 10-Q for the quarterly period ended March 31, 2007, its Annual Report on Form 10-K for the year ended December 31, 2006 and in Pharmion's other filings with the U.S. Securities and Exchange Commission. Forward-looking statements speak only as of the date on which they are made, and Pharmion undertakes no obligation to update publicly or revise any forward-looking statement, whether as a result of new information, future developments or otherwise. Pharmion also disclaims any duty to comment upon or correct information that may be contained in reports published by the investment community.

# # #

-------------------

(Back to top)

PHARMION AND METHYLGENE REPORT PRELIMINARY DATA FOR MGCD0103 AT THE 43rd AMERICAN SOCIETY OF CLINICAL ONCOLOGY (ASCO) ANNUAL MEETING

HDAC INHIBITOR MGCD0103 DEMONSTRATES substantial RESPONSE RATE IN TWO CLINICAL TRIALS

40% Response Rate and 45% Disease Control Rate in Single-Agent Phase II Trial in Refractory or Relapsed Hodgkin's Lymphoma Patients

30% Response Rate (37% at Relevant Active Doses) in Phase I/II Combination Trial with Vidaza(r) in MD
'"/>




Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29

Related medicine technology :

1. Genetic Analysis Systems Enter the Clinical Mainstream
2. Clinical Study Shows Regenecare Relieves Pain and Itching of Skin Rashes Caused by Widely Used Cancer Drugs
3. Large Geographic Differences in EpiPen Prescriptions in the U.S., From the Journal of Allergy and Clinical Immunology
4. Clinical Data Suggest Decreased Bleeding Risk in People With Severe Hemophilia A While Maintaining Factor VIII Levels Above One Percent
5. Biofrontera AG Announces Clinical Study Confirms Excellent Efficacy of BF-200 ALA In Actinic Keratosis
6. Halozyme Therapeutics Enhanze Technology Large Protein Molecule Therapeutic Clinical Trial Results Presented at the 34th Annual Meeting of the Controlled Release Society
7. Corgenix Reports New Clinical Data Correlating AtherOx Technology With Vascular Disease
8. AVI BioPharma Partner Cook Medical Announces Completion of Patient Enrollment for APPRAISAL Phase II Clinical Trial for Treatment of Cardiovascular Disease
9. Protox Announces Positive Clinical Data from Prostate Cancer Study
10. AM-Pharma Announces Positive Results of Phase IIa Clinical Trial with Alkaline Phosphatase For Ulcerative Colitis
11. Cougar Biotechnology Announces Presentation of Positive CB7630 Clinical Data at ESMO Conference
Post Your Comments:
(Date:11/21/2014)... Nov. 20, 2014 /PRNewswire/-- CANTEL MEDICAL CORP. (NYSE: CMN ... Executive Officer, will be presenting at the 26 th ... Hotel in New York . The formal ... PM ET. In addition, Mr. Krakauer and Jorgen B. ... one-on-one meetings during the day. An audio ...
(Date:11/21/2014)... LAVAL, QC , Nov. 20, 2014 /CNW Telbec/ ... pleased to announce the following appointments: ... leadership team in the newly created role of Chief ... a BioPhotonic system using topical photoconverter gel for the ... as surgical and traumatic wounds, recently approved in ...
(Date:11/21/2014)... , 21. November 2014 Michael DeMarco ... am Morgen des 14. Februar 2014 zugetragen hat. Seine ... kaum vergessen. Video - http://youtu.be/5cVoMCe0uiE ... dabei war, mein morgendliches Training zu machen", erzählt ... der Zeit begeisterte Anhänger der CrossFit-Trainingsmethode. Ich ...
Breaking Medicine Technology:KLOX Technologies announces executive appointments 2KLOX Technologies announces executive appointments 3KLOX Technologies announces executive appointments 4Tochter rettet Vater durch Herz-Lungen-Wiederbelebung vor plötzlichem Herztod 2Tochter rettet Vater durch Herz-Lungen-Wiederbelebung vor plötzlichem Herztod 3
... (OTCQB/OTCBB: GOVX), an Atlanta-based biopharmaceutical firm developing vaccines to ... announced that the NIH-funded HIV Vaccine Trials Network (HVTN) ... the company,s second-generation HIV vaccine. The second-generation vaccine is ... a Phase 2a clinical trial) except for the inclusion ...
... -- Gentech Pharmaceutical announced today that Dr. Stan Headley ... PhenTabz and ADDTabz ... the world of Integrative Medicine. He holds a Doctorate of ... family medicine at Creighton University School of Medicine and St. ...
Cached Medicine Technology:HIV Vaccine Trials Network Opens Enrollment for Phase 1 Trial of GeoVax Labs' Second Generation HIV Vaccine 2HIV Vaccine Trials Network Opens Enrollment for Phase 1 Trial of GeoVax Labs' Second Generation HIV Vaccine 3HIV Vaccine Trials Network Opens Enrollment for Phase 1 Trial of GeoVax Labs' Second Generation HIV Vaccine 4Gentech Pharmaceutical Appoints New Medical Director for PhenTabz/ADDTabz 2
(Date:11/21/2014)... (HealthDay News) -- The cost of diabetes care in ... years, climbing to more than $322 billion annually, a ... were seen with prediabetes care, which have risen 74 ... the researchers added. In 2012, excess medical costs ... $1,000 for every American. That total includes $244 billion ...
(Date:11/21/2014)... Nov. 21, 2014 (HealthDay News) -- Scientists say they,ve mapped ... extracted from a British man,s brain, in hopes it might ... Nov. 21 in the journal Genome Biology , the ... man of Chinese ethnicity. "This infection is so rare ... was not diagnosed ... until the worm was pulled out ...
(Date:11/21/2014)... 21, 2014 MLF Biotech, Inc. has ... . Liv-Pro® Probiotics for Pets helps maintain digestive health ... a pet's intestinal flora after it experiences a period ... Liv-Pro Probiotics for Pets is a proprietary blend of ... seven live active bacteria strains that are safe and ...
(Date:11/21/2014)... November 21, 2014 Saint Luke’s ... With The Guidelines®–Heart Failure Gold-Plus Quality Achievement Award ... the American Heart Association/American College of Cardiology Foundation ... patients. , Get With The Guidelines–Heart Failure is ... provide the most up-to-date, research-based guidelines with the ...
(Date:11/21/2014)... Big Bud Farms announced today that ... Innovations with Ed Begley Jr., airing via Discovery Channel ... Big Bud Farms, growers of legal medical marijuana, provide ... of medical marijuana. , This segment of Innovations takes ... of products for medicating. Viewers will learn about the ...
Breaking Medicine News(10 mins):Health News:Cost of Diabetes Care Keeps Climbing, Report Shows 2Health News:Ick! Tapeworm Infecting Man's Brain Yields Genetic Secrets 2Health News:MLF Biotech Introduces Liv-Pro Probiotics for Pets 2Health News:Saint Luke’s Mid America Heart Institute Awarded Get With The Guidelines Heart Failure Gold-Plus Quality Achievement Award 2Health News:Saint Luke’s Mid America Heart Institute Awarded Get With The Guidelines Heart Failure Gold-Plus Quality Achievement Award 3Health News:Saint Luke’s Mid America Heart Institute Awarded Get With The Guidelines Heart Failure Gold-Plus Quality Achievement Award 4Health News:Big Bud Farms to be Featured in Upcoming Episode of Innovations with Ed Begley Jr. 2
... found that the frequency with which critically-ill patients developed ... multidisciplinary medical center such as Mayo Clinic compared to ... National Healthcare Safety Network (NHSN). This is good news ... generally strong across the U.S. in intensive care units, ...
... children becoming unconscious after swallowing Aqua Dots beads led to ... the time, it was widely reported that the potentially toxic ... benign but more expensive 1,5-pentanediol (PD) in the manufacture of ... Suchard of the University of California, Irvine confirms these reports, ...
... Nancy Pelosi,issued the following statement today following reports on ... health has been met with great concern., "Senator ... Americans and a,great fighter for America,s children, workers and ... serve him well in this,challenge., "Our thoughts and ...
... spine conference and exhibition draws specialists from across the ... ... Medical Werks, a leading provider of,ceramic components for motion preserving, total disc ... be held in Geneva, Switzerland, May 26-31., The foremost scientific societies ...
... of,America, Inc. today announced that Lindsay Goldberg has ... will use the funds to close,several identified acquisitions ... http://www.newscom.com/cgi-bin/prnh/20071218/CLTU087LOGO ), Ambulatory Services of ... care services in partnership with physicians. In,December 2007, ...
... Foundation,today released the following statement by its founder and ... learned today that Senator Kennedy, a champion for healthcare ... himself facing this,disease. I have no doubt that Senator ... strength that have shaped his lifelong service to this,nation ...
Cached Medicine News:Health News:Intensive care units' prevention of pneumonia in critically-ill patients generally strong 2Health News:Study finds that recalled Aqua Dots did contain poisonous chemical 2Health News:C5 Medical Werks Joins in Sponsoring SpineWeek 2008 in Geneva, Switzerland 2Health News:Ambulatory Services of America, Inc. Announces Investment by Lindsay Goldberg 2
... surgery, the Alexis Wound Retractor provides ... from contamination. For open surgery, the ... minimizing the incision size. For laparoscopic ... in offering retraction and protection when ...
... Concept is a revolutionary motorized electronic ... in mind, Pipetman Concept features exclusive ... connectionthe only one of its kind ... Diamond Tips from Gilson, this product ...
The Express Plus clinical chemistry analyzer is a fully automated walk away system designed for maximum productivity, convenience and reliability....
... Wireless, internet-based alarm/monitoring ... compliance and security ... system. The Celaris ... incorporates communication technology, ...
Medicine Products: